Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WELL Health Technologies Corp WHTCF


Primary Symbol: T.WELL Alternate Symbol(s):  T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.


TSX:WELL - Post by User

Comment by Noshortsallowedon Oct 23, 2022 8:43am
92 Views
Post# 35041761

RE:RE:RE:RE:RE:RE:RE:RE:Tax loss arrives Earlier this year

RE:RE:RE:RE:RE:RE:RE:RE:Tax loss arrives Earlier this year Why not wait for Q3 to assess? But if you insist, 8x EV/EBITDA for 2023 puts the stock at $9.  And with organic growth of 15% in Q1 and 21% in Q2 of 2022 this might suggest the multiple should be higher.  The strong US dollar is another factor that may speed up the profitably timeline so I think the above analysis is conservative. Of course you are probably going to say its currently worth less than their currently yearly revenues right?  What's the point of evening engaging with you trolls.
<< Previous
Bullboard Posts
Next >>